SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

28482.27

EPS(TTM)

Face Value()

Div & Yield %

72.04

1.04

Back

L&T Finance consolidated net profit rises 17.91% in the December 2025 quarter

Jan 17,2026

Net profit of L&T Finance rose 17.91% to Rs 738.61 crore in the quarter ended December 2025 as against Rs 626.40 crore during the previous quarter ended December 2024. Sales rose 11.73% to Rs 4578.27 crore in the quarter ended December 2025 as against Rs 4097.58 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4578.27	4097.58	12
OPM %	60.68	59.10	-
PBDT	1078.38	860.09	25
PBT	1020.68	823.90	24
NP	738.61	626.40	18

73,583.22 -1,690.23 ( -2.25%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)